Four insights:
1. The company is developing therapies to improve functional recovery of patients with spinal cord injuries.
2. GTX Medical BV is designing an implantable spinal cord stimulation device with real-time motion feedback known as targeted epidural spine stimulation.
3. The company is also developing a transcutaneous spinal cord stimulation device to restore upper limb movement and hand function.
4. The Christopher & Dana Reeve Foundation, a nonprofit focused on advancing spinal cord injury research, will be a shareholder in the company.
More articles on devices:
7 big moves for Hospital for Special Surgery in 2019
5 highest paying physician specialties — Neurosurgeon No. 1 at $401k
Dr. Thomas Loftus: How a single-payer system would harm spine practice in the US
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.